| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.8 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |